Najafi, Masoud and Tavakol, Shima and Zarrabi, Ali and Ashrafizadeh, Milad (2022) Dual role of quercetin in enhancing the efficacy of cisplatin in chemotherapy and protection against its side effects: a review. Archives of Physiology and Biochemistry, 128 (6). pp. 1438-1452. ISSN 1381-3455 (Print) 1744-4160 (Online)
Full text not available from this repository. (Request a copy)
Official URL: https://dx.doi.org/10.1080/13813455.2020.1773864
Abstract
Chemotherapy has opened a new window in cancer therapy. However, the resistance of cancer cells has dramatically reduced the efficacy of chemotherapy. Cisplatin is a chemotherapeutic agent and its potential in cancer therapy has been restricted by resistance of cancer cells. As a consequence, the scientists have attempted to find new strategies in elevating chemotherapy efficacy. Due to great anti-tumour activity, naturally occurring compounds are of interest in polychemotherapy. Quercetin is a flavonoid with high anti-tumour activity against different cancers that can be used with cisplatin to enhance its efficacy and also are seen to sensitise cancer cells into chemotherapy. Furthermore, cisplatin has side effects such as nephrotoxicity and ototoxicity. Administration of quercetin is advantageous in reducing the adverse effects of cisplatin without compromising its anti-tumour activity. In this review, we investigate the dual role of quercetin in enhancing anti-tumour activity of cisplatin and simultaneous reduction in its adverse effects.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | cancer therapy; chemotherapy; Cisplatin; quercetin; side effect |
| Divisions: | Sabancı University Nanotechnology Research and Application Center |
| Depositing User: | Ali Zarrabi |
| Date Deposited: | 21 Mar 2023 14:53 |
| Last Modified: | 21 Mar 2023 14:53 |
| URI: | https://research.sabanciuniv.edu/id/eprint/45069 |
Actions (login required)
- View Item